Evidence map›Paper›PMID 41703496›Full record

ArticleBMC public health2026

First-time detection of treatable congenital heart disease - a study of school-aged children in the community of three regions in China.

Kai Bai, Teng Wang, Shuyue Zhang, Liping He, Yan Wang, Xiaoting Ming, Yue Gao, Krishna Garu, Tao Wang, Miao Zhao and 5 more

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kai Bai *Fuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Teng Wang *Fuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Shuyue ZhangFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Liping HeSchool of Public Health, Kunming Medical University, Kunming, 650500, China.
Yan WangFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Xiaoting MingFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Yue GaoFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Krishna GaruSchool of Public Health, Kunming Medical University, Kunming, 650500, China.
Tao WangYunnan Population and Family Planning Research Institute, No.146, Qingnian Road, Wuhua District, Kunming, Yunnan, 650021, China.
Miao ZhaoFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Wei LuoFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China.
Yuling LuSchool of Public Health, Kunming Medical University, Kunming, 650500, China.
Lin DuoFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China. duolin@hotmail.com.
Yu XiaFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China. xy19930551114@163.com.
Jiang LuFuwai Yunnan Hospital, Chinese Academy of Medical Science, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650102, China. 896758207@qq.com.

Funding

The Yunnan Pan Xiangbin Expert Workstation under the Yunnan Provincial Project for Scientific and Technological Talents and Platforms Project 202305AF150069Yunnan Fundamental Research Projects 202301AY070001-045
6 · The paper itself

Abstract

backgroundCongenital heart disease (CHD) is a leading cause of birth defect-related morbidity and mortality globally. While neonatal screening programs exist, the undiagnosed burden of treatable CHD among school-aged children in low- and middle-income countries (LMICs) like China remains sparse. This manuscript aimed to determine the epidemiology and identify factors associated with the First-Time Detection of Eligible-Treatment congenital heart disease (FTET-CHD) in a community-based sample of school children.

methodsA large-scale cross-sectional study was conducted from June 2024 to June 2025 across three Chinese regions (Yunnan, Xinjiang, and Chongqing). A total of 1,024,531 children aged 3–18 years were screened. Diagnosis was confirmed by echocardiography. Among the 3,376 children diagnosed with CHD, 484 with treatable CHD were enrolled and categorized as either FTET-CHD (no prior diagnosis) or prior-detected CHD (PDET-CHD). Demographic, clinical, and socioeconomic data were collected. Multivariable logistic regression and SHAP (Shapley Additive Explanations) analysis were employed to identify key factors associated with FTET-CHD.

resultsOf the 484 children with treatable CHD (median age 10 years; 40.7% male), a striking 67.1% (n = 325) were identified as FTET-CHD. Significant geographical variation was observed, with Xinjiang having a significantly higher proportion of FTET-CHD than Yunnan (82% vs. 58.5%; adjusted OR = 4.818, 95% CI: 2.510–9.230). Key factors associated with reduced odds of FTET-CHD (i.e., protective against delayed diagnosis) included having commercial health insurance (vs. public insurance; OR = 0.191, 95% CI: 0.051–0.716) and higher annual household healthcare expenditure (OR = 0.972 per 1000 CNY, 95% CI: 0.950–0.995). Paradoxically, FTET-CHD children reported significantly higher quality of life (QoL) scores than PDET-CHD children (88.0 vs. 78.0). SHAP analysis confirmed geographic region and QoL score as the most influential predictors in the model.

conclusionThis study revealed a critically still high prevalence of previously undiagnosed treatable CHD among school-aged children in China, indicating an existing gap in early detection. The findings underscored the impact of socioeconomic and geographic disparities on diagnostic delay. Advocacy for school-age echocardiographic screening programs, especially in low- and middle-income countries (LMICs), is essential to reduce CHD-related burden and ensure timely treatment.

Indexed as

Heart Defects, CongenitalAdolescentChildChild, PreschoolChinaCross-Sectional StudiesEchocardiographyFemaleHumansMaleCongenital heart diseaseDelayed diagnosisFirst-time detectionSchool-age children

Identifiers

PMID41703496
PMCPMC13019724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.